Aurobindo gets USFDA nod for Clindamycin Hydrochloride
MUMBAI, Aug 27 (Reuters) - Aurobindo Pharma Ltd (ARBN.BO: Quote, Profile, Research) said on Thursday it has received approval from the US Food and Drug Administration for Clindamycin Hydrochloride Capsules.
The drug, which is a generic equivalent of Cleocin Hydrochloride capsules, is used to treat certain bacterial infections and has a market size of about $55 million, the company said in a statement to the stock exchange.
(Reporting by Jasudha Kirpalani; Editing by Ramya Venugopal)
© Thomson Reuters 2009 All rights reserved
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India during the Reuters India Investment Summit in Mumbai and Bangalore. Full Coverage | Blog
PLAYBOY SALE
An icon bows to changing times
With his Playboy Enterprises in talks to be sold for about $300 million, the 83 year-old Hugh Hefner will be giving up control over the iconic adult entertainment empire he founded that was instrumental in shaping society's opinions on nudity, sex and free speech. Full Article
India
US
UK
